Clinical assessment for high-risk patients with non-alcoholic fatty liver disease in primary care and diabetology practices.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

Primary care practitioners (PCPs) and diabetologists are at the frontline of potentially encountering patients with NASH. Identification of those at high risk for adverse outcomes is important.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Aliment Pharmacol Ther

Title: Alimentary pharmacology & therapeutics

Publisher: Wiley

ISSN (Electronic): 1365-2036

ISSN (Print): 0269-2813

Publication date (Electronic): August 2020

Volume: 52

Issue: 3

Affiliations

[1 ] Falls Church, VA, USA.

[2 ] Boston, MA, USA.

[3 ] San Antonio, TX, USA.

[4 ] Los Angeles, CA, USA.

[5 ] New York City, NY, USA.

[6 ] Charlottesville, VA, USA.

[7 ] Detroit, MI, USA.

[8 ] Baltimore, MD, USA.

[9 ] Richmond, VA, USA.

[10 ] Chicago, IL, USA.

[11 ] Sioux Falls, SD, USA.

[12 ] Washington, DC, USA.

Article

DOI: 10.1111/apt.15830

PubMed ID: 32598051

SO-VID: e6b3fb3f-788d-4845-abca-11c6c7edc97c

History

Data availability:

Comments

Comment on this article

scite_

Cited by 41

See all cited by